Castle Biosciences Inc
CSTL
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.08B
Close$
$33.86
5.5% downside
Current Fair Value
5.5% downsideOvervalued by 5.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.08 Billion |
|---|---|
| Enterprise Value | $1.05 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.83 |
| Beta | 1 |
| Outstanding Shares | 30,399,000 |
Return
| Return on Equity | -4.13% |
|---|---|
| Return on Assets | -3.46% |
| Return on Invested Capital | -4.74% |
Valuation & Multiples
| P/E Ratio | -53.59 |
|---|---|
| PEG | 36.82 |
| Price to Sales | 3.26 |
| Price to Book Ratio | 2.39 |
| Enterprise Value to Revenue | 2.95 |
| Enterprise Value to EBIT | -44.09 |
| Enterprise Value to Net Income | -55 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.08 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 3, 2026
EPS Estimate
$-0.44
Average shareholder expectationRevenue Estimate
$86.37 M
Average shareholder expectationNext Earnings Call
Expected Date
November 2, 2026
EPS Estimate
$-0.38
Average shareholder expectationRevenue Estimate
$92.13 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 19.35% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 91.07%▼ 1.30% |
|---|---|
| Total Invested | $660.03M▼ 2.62% |
| Investors Holding | 180▼ 10.00% |
ESG Score
No data